Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 2

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Genitourinary 2Gastrointestinal 2Thoracic 1Other solid neoplasm 1NET 1Head & Neck 1Gynecologic 1Endocrine 1CNS 1Breast 1

Conditions

Breast Neoplasms 870Neoplasms 657Prostatic Neoplasms 448Lung Neoplasms 361Colorectal Neoplasms 333Carcinoma, Non-Small-Cell Lung 324Leukemia, Myeloid, Acute 256Pancreatic Neoplasms 222Brain Neoplasms 204Multiple Myeloma 202Neoplasm Metastasis 198Carcinoma, Hepatocellular 182Head and Neck Neoplasms 178Glioblastoma 169Precursor Cell Lymphoblastic Leukemia-Lymphoma 167Melanoma 156Ovarian Neoplasms 151Squamous Cell Carcinoma of Head and Neck 150Rectal Neoplasms 135Recurrence 133Hematologic Neoplasms 127Sarcoma 125Uterine Cervical Neoplasms 124Stomach Neoplasms 118Glioma 117Triple Negative Breast Neoplasms 116Carcinoma, Renal Cell 116Motor Activity 101Urinary Bladder Neoplasms 99Colonic Neoplasms 99

Interventions

Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Endodermal Sinus Tumor × 90 days × Clear all
NCT06638931 2026-04-15

ANTARES

Instituto do Cancer do Estado de São Paulo

Phase 2 Recruiting
28 enrolled
BreastCNSEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckNETOther solid neoplasmSarcomaThoracic

Urachal adenocarcinoma, Urachal cancer, Fibrolamellar hepatocellular carcinoma, Secretory breast carcinoma, Carcinoma, Ovarian Epithelial, Adrenal Gland Neoplasms, Anus Neoplasms, Biliary Tract Neoplasms, Carcinosarcoma, Carcinoma, Adenoid Cystic, Fallopian Tube Neoplasms, Fibrosarcoma, Gallbladder Neoplasms, Granulosa Cell Tumor, Hemangiosarcoma, Leiomyosarcoma, Mesothelioma, Neuroblastoma, Parathyroid Neoplasms, Penile Neoplasms, Sarcoma, Sarcoma, Kaposi, Osteosarcoma, Thyroid Neoplasms, Trophoblastic Neoplasms, Urethral Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Hepatoblastoma, Endodermal Sinus Tumor, Neuroectodermal Tumors, Primitive, Cholangiocarcinoma, Sertoli-Leydig Cell Tumor, Neurofibrosarcoma, Hemangioblastoma, Neuroendocrine Tumors

NCT04715191 2026-04-06

Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors

Baylor College of Medicine

Phase 1 Recruiting
24 enrolled
GastrointestinalGenitourinarySarcoma

Liposarcoma, Liver Neoplasms, Wilms Tumor, Rhabdomyosarcoma, Endodermal Sinus Tumor, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡